Guardant Health’s blood test designed to help screen the population for hidden cases of colorectal cancer may have taken a ...

WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and ...

Results from the study showed that the cell-free DNA blood-based test had a sensitivity of 83.1% for CRC and a specificity of ...

Agency scientists highlighted the risk in materials posted ahead of a Thursday advisory panel meeting for the Guardant Health blood test.

While propofol sedation is associated with improved serrated polyp detection, propofol sedation may not improve adenoma detection. Propofol sedation during a colonoscopy is associated with increased ...

Guardant Health (GH) stock fell after FDA reviewers expressed concerns about its Shield blood test for colorectal cancer ...

vumc.nl Objective: This study aimed to identify the oncogenes at 20q involved in colorectal adenoma to carcinoma progression by measuring the effect of 20q gain on mRNA expression of genes in this ...

FAP is a substantially genetic orphan disease for which there are no approved therapeutic options; the current standard of care is surveillance and surgery Phase 3 FAP program is supported by a $17 ...